(7) E uropean Parliament and Council, Regulation (EC) No. 1223/2009 of the European. Parliament and of the Council of 30 November 2009 on Cosmetic Products (Offi cial Journal of the European Union L342/59, 2009), https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:342:0059:0209:e n:PDF. (8) h ttps://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=352. (9) H . Gonzalez, A. Farbrot, O. Larkö, and A. M. Wennberg, Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br. J. Dermatol., 154, 337–340 (2006). (10) Y. A. G o maa, L. K. El-Khordagui, N. A. Boraei, and I. A. Darwish, Chitosan microparticles incorporat- ing a hydrophilic sunscreen agent. Carbohydr. Polym., 81, 234–242 (2010). (11) D. Gogna, S. K. Jain, A. K. Yadav, and G. P. Agrawal, Microsphere-based improved sunscreen formula- tion of ethylhexyl methoxycinnamate, Curr. Drug Deliv., 4, 153–159 (2007). (12) I. Hanno, C . Anselmi, and K. Bouchemal, Polyamide nanocapsules and nano-emulsion containing par- sol mcx and parsol 1789, in vitro release, ex vivo skin penetration and photo-stability studies, Pharm. Res. (N. Y.)., 29, 559–573 (2012). (13) V. Weiss-Angel , S. Bourgeois, J. Pelletier, S. Stanisçuaski Guterres, H. Fess, and M. A. Bolzinger, De- velopment of an original method to study drug release from polymeric nanocapsules in the skin, J. Pharm. Pharmacol., 62, 35–45 (2010). (14) B. Albertini, M. Mezzena, N. Pas s erini, L. Rodriguez, and S. Scalia, Evaluation of spray congealing as a technique for the preparation of highly loaded solid lipid microparticles containing the sunscreen agent avobenzone. J. Pharmacol. Sci., 98, 2759–2769 (2009). (15) S. Nikolic, C. M. Keck, C. Ansel m i, and R. H. Muller, Skin photoprotection improvement, synergistic interaction between lipid nanoparticles and organic uv fi lters. Int. J. Pharm., 414, 276–328 (2011). (16) S. Scalia and M. Mezzena, Incorp o ration in lipid microparticles of the uva fi lter, butyl methoxydibenzo- ylmethane combined with the UVB fi lter, octocrylene, effect on photostability. AAPS Pharm. SciTech., 10, 384–390 (2009). (17) L. Perioli, V. Ambrogi, B. Berti n i, M. Ricci, M. Nocchetti, L. Latterini, and C. Rossi, Anionic clays for sunscreen agent safe use, photoprotection, photostability and prevention of their skin penetration. Eur. J. Pharm. Biopharm., 62, 185–193 (2006). (18) S. Scalia, R. Tursilli, and V. Ia n nuccelli, Complexation of the sunscreen agent, 4-methylbenzylidene camphor with cyclodextrins, effect on photostability and human stratum corneum penetration, J. Phar- maceut. Biomed. Anal., 44, 29–34 (2007). (19) C. Anselmi, M. Centini, M. Maggiore , N. Gaggelli, M. Andreassi, A. Buonocore, G. Beretta, and R. M. Facino, Non-covalent inclusion of ferulic acid with α-cyclodextrin improves photo-stability and deliv- ery, NMR and modeling studies, J. Pharmaceut. Biomed. Anal., 46, 645–652 (2008). (20) S. Simeoni, S. Scalia, and H. A. E. Benson, Infl uence of cyclodextrins on in vit r o human skin absorption of the sunscreen butyl-methoxydibenzoylmethane, Int. J. Pharm., 280, 163–171 (2004). (21) G. L. Negve Coelho, C. Braga Domelas, K. C. Costa Soares, E. P. dos Santos, A. L. V ergnanini, T. C. dos Santos, C. R. Rodrigues, H. C. Castro, L. R S. Dias, and L. M. Cabral, Preparation and evaluation of inclusion complexes of commercial sunscreens in cyclodextrins and montmorillonites, performance and substantivity studies, Drug Dev. Ind. Pharm., 34, 536–546 (2008). (22) S. Coutinho Cdos, E. P. Dos Santos, and C. R. Mansur, Nanosystems in photoprotecti o n, J. Nanosci. Nanotechnol., 15, 9679–9688 (2015). (23) G. Fytianos, A. Rahdar, and G. Z. Kyzas, Nanomaterials in cosmetics: recent update s , Nanomaterials (Basel), 10, 979 (2020). (24) Q. Li, T. Cai, Y. Huang, X. Xia, S. P. C. Cole, and Y. Cai, A review of the struct u re, preparation, and application of NLCS, PNPS and PLNS, Nanomaterials (Basel), 7, 122 (2017). (25) I. Chauhan, M. Yasir, M. Verma, and A. P. Singh, Nanostructured lipid carriers, a g roundbreaking ap- proach for transdermal drug delivery, Adv Pharm Bull, 10, 150–165 (2020). (26) K. W. Kim, K. S. Kim, H. Kim, S. H. Lee, J. H. Park, J. H. Han, S. H. Seok, J. Par k , Y. Choi, Y. I. Kim, J. K. Han, and J. H. Son, Terahertz dynamic imaging of skin drug absorption, Opt. Expr., 20(9), 9476–9484 (2012). (27) A. Varvaresou, Percutaneous absorption of organic sunscreens, J. Cosmet. Dermatol. , 5, 53–57 (2006). (28) M. Munem, A. Djuphammar, L. Sjölander,L. Hagvall, and P. Malmberg, Animal- free sk i n permeation analysis using mass spectrometry imaging, Toxicol. Vitro, 71, 105062 (2021). (29) M. Schlumpf and W. Lichtensteiger, Endocrine-active ultraviolet fi lters and cosmetics, Endo c r. Disrupt. Chem. Food, Ian Shaw, Ed., Woodhead Publishing Ltd., Cambridge, UK, 519–540 (2009). DISTRIBUTION OF UV FILTERS ON THE SKIN 321

(30) D. Seidlova-Wuttke, J. Christoffel, G. Rimoldi, H. Jarry, and W. Wuttke, Comparison of effec ts of es- tradiol with those of octylmethoxycinnamate and 4-methylbenzylidene camphor on fat tissue, lipids and pituitary hormones, Toxicol. Appl. Pharmacol., 214, 1–7 (2006). (31) J. Wang, L. Pan, S. Wu, L. Lu, Y. Xu, Y. Zhu, M. Guo, and S. Zhuang, Recent advances on end o crine disrupting effects of UV fi lters, Int. J. Environ. Res. Publ. Health, 13, 782 (2016). (32) M. Krause, A. Klit, M. Blomberg Jensen, T. Søeborg, H. Frederiksen, M. Schlumpf, W. Lichten s teiger, N. E. Skakkebaek, and K. T.Drzewiecki, Sunscreens: are they benefi cial for health? An overview of en- docrine disrupting properties of UV-fi lters, Int. J. Androl., 35, 424–436 (2012). (33) M. K. Matta, J. Florian, R. Zusterzeel, N. R. Pilli, V. Patel D. A. Volpe, Y. Yang, L. Oh, E. Basha w, I. Zineh, C. Sanabriaand, S. Kemp, A. Godfrey, S. Adah, S. Coelho, J. Wang, L.-A. Furlong, C. Ganley, T. Michele, and D. G. Strauss, Effect of sunscreen application on plasma concentration of sunscreen active ingredients: a randomized clinical trial, J. Am. Med. Assoc., 323(3), 256–267 (2020). (34) H. Frederiksen, M. Krause, N. Jørgensen, A. Rehfeld, N. E. Skakkebæk, and A. M. Andersson, UV fi lt e rs in matched seminal fl uid-, urine-, and serum samples from young men, J. Expo. Sci. Environ. Epidemiol., 31, 345–355 (2020). (35) J. D. Bos and M. M. Meinardi, The 500 Dalton rule for the skin penetration of chemical compounds and drugs, Exp. Der m atol., 9, 165–169 (2009). (36) F. Benech-Kieffer, P. Wegrich, R. Schwarzenbach, G. Klecak, T. Weber, J. Leclaire, and H. Schaefer, Percutaneous ab s orption of sunscreens in vitro, interspecies comparison, skin models and reproducibility aspects, Appl. Skin Physiol., 13, 324–335 (2000). (37) L. Roussel, E. Gilbert, D. Salmon, C. Serre, B. Gabard, M. Haftek, H. I. Maibach, and F. Pirot, Measurement, analysis a nd prediction of topical UV fi lter bioavailability, Int. J. Pharm., 478(2), 804–810 (2015). (38) M. Vettor, S. Bourgeois, H. Fessi, J. Pelletier, P. Perugini, F. Pavanetto, and M. A. Bolzinger, Skin ab- sorption studi e s of octyl-methoxycinnamate loaded poly(D,L-Lactide) nanoparticles, estimation of the UV fi lter distribution and release behaviour in skin layers, J. Microencapsul., 27, 253–262 (2010). (39) G. J. Nohynek, E. K. Dufour, and M. S. Roberts, Nanotechnology, cosmetics, and the skin, is there a health risk? Skin P harmacol. Physiol., 21, 136–149 (2008). (40) C. G. J Hayden, S. E Cross, C. Anderson, N. A. Saunders, and M. S. Roberts, Sunscreen penetration of human skin and rel ated keratinocyte toxicity after topical application, Appl. Skin Physiol., 18, 170–174 (2005). (41) T. Søeborg, L.H. Basse, B. Halling-Sørensen, Risk assessment of topically applied products, Toxicology, 236, 140–148 (2007). (42) L. Montenegro, R. Turnaturi, C. Parenti, and L. Pasquinucci, In vitro evaluation of sunscreen safety, effects of the v e hicle and repeated applications on skin permeation from topical formulations, Pharmaceutics, 10, 27 (2018). (43) S. L. Schneider and H. W. Lim, A review of inorganic UV fi lters zinc oxide and titanium dioxide, Pho- todermatol. Photoi m munol. Photomed., 35(6), 442–446 (2019). (44) K. Adachi, N. Yamada, Y. Yoshida, and O. Yamamoto, Subchronic exposure of titanium dioxide nanoparticles to hairless r at skin, Exp. Dermatol., 22, 278–283 (2013). (45) N. Sadrieh, A. M. Wokovich, N. V. Gopee, J. Zheng, D. Haines, D. Parmiter, P. H. Siitonen, C. R. Cozart, A. K. Patri, S . E. McNeil, P. C. Howard, W. H. Doub, and L. F. Buhse, Lack of signifi cant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size Tio2 particles, Toxicol. Sci., 115, 156–166 (2010). (46) I. Karlsson, L. Hillerström, A. L., Stenfeldt, J. Mårtensson, and A. Börje, Photodegradation of dibenzoyl- methanes, poten t ial cause of photocontact allergy to sunscreens, Chem. Res. Toxicol., 22, 1881–1892 (2009). (47) G. J. Mturi and B. S. Martincigh, Photostability of the sunscreening agent 4- tert-butyl-4′- methoxydibenzoylmethane (avobenzone) in solvents of di f ferent polarity and proticity, Photochem. Photobiol., 200, 410–420 (2008). (48) A. M. Bryden, H. Moseley, S. H. Ibbotson, M. M. U. Chowdhury, M. H. Beck, J. Bourke, J. English, P. Farr, I. S. Foulds, D. J. Gawkrodger, S. George, D. I . Orton, S. Shaw, J. McFadden, P. Norris, P. Podmore, S. Powell, L. E. Rhodes, J. Sansom, M. Wilkinson, H. van Weelden, and J. Ferguson, Photopatch testing of 1155 patients, results of the U.K. multicentre photopatch study group, Br. J. Dermatol., 155, 737– 747 (2006). (49) H. Gustavsson Gonzalez, A. Farbrot, and O. Larkö, Percutaneous absorption of benzophenone-3, a common component of topical sunscreens, Clin. Exp. Dermato l ., 27, 691–694 (2002). (50) N. R. Janjua, B. Kongshoj, A. M. Andersson, and H. C. Wulf, Sunscreens in human plasma and urine after repeated whole-body topical application, J. Eur. Acad. De r matol. Venereol., 22, 456–461 (2008). JOURNAL OF COSMETIC SCIENCE 322